ALBO logo

Albireo Pharma (ALBO) Selling, General & Administrative Expenses

Annual SGA

$69.57 M
+$27.12 M+63.89%

December 31, 2021

Summary

Performance

1-Year Change

+63.89%

3-Year Change

+285.19%

5-Year Change

+356.31%

15-Year Change

+356.31%

ALBO SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$69.57 M
ALBO annual SGA is currently at an all-time high

3-Year Low

$69.57 M
ALBO annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
ALBO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
ALBO next annual earnings announcement has not yet been scheduled

OtherALBOexpensesmetrics:

Annual Total Expenses

$164.06 M
ALBO annual total expenses is $164.06 million

Annual Operating Expenses

$162.71 M
ALBO annual total operating expenses is $162.71 million

Annual Cost Of Goods Sold

$1.36 M
ALBO annual cost of goods sold is $1.36 million

Annual Interest Expense

$13.93 M
ALBO annual interest expense is $13.93 million

Quarterly SGA

$20.56 M
-$1.04 M-4.80%

September 30, 2022

Summary

Performance

3-Month Change

-4.8%

1-Year Change

+16.76%

3-Year Change

+242.16%

5-Year Change

+454.44%

ALBO Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$21.60 M
ALBO quarterly SGA is currently -4.80% below its historical high of $21.60 million

3-Year Low

$16.86 M
ALBO quarterly SGA is currently +22.01% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
ALBO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
ALBO next earnings announcement has not yet been scheduled

OtherALBOexpensesmetrics:

Quarterly Total Expenses

$44.49 M
ALBO quarterly total expenses is $44.49 million

Quarterly Operating Expenses

$43.88 M
ALBO quarterly total operating expenses is $43.88 million

Quarterly Cost Of Goods Sold

$612.00 K
ALBO quarterly cost of goods sold is $612.00 thousand

Quarterly Interest Expense

$2.53 M
ALBO quarterly interest expense is $2.53 million

TTM SGA

-$1.45 B
-$131.15 M-9.96%

September 30, 2022

Summary

Performance

3-Month Change

-2010.54%

1-Year Change

-2363.73%

3-Year Change

-6407.54%

5-Year Change

-6407.54%

ALBO TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.16 M

3-Year Low

-$1.45 B
ALBO TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
ALBO previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
ALBO next earnings announcement has not yet been scheduled

OtherALBOexpensesmetrics:

Annual Total Expenses

$164.06 M
ALBO annual total expenses is $164.06 million

Annual Operating Expenses

$162.71 M
ALBO annual total operating expenses is $162.71 million

TTM Cost Of Goods Sold

$2.55 M
ALBO TTM cost of goods sold is $2.55 million

TTM Interest Expense

$11.41 M
ALBO TTM interest expense is $11.41 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$69.57 M
ALBO annual SGA is $69.57 million

Annual Operating Expenses

$162.71 M
ALBO annual total operating expenses is $162.71 million

Annual Cost Of Goods Sold

$1.36 M
ALBO annual cost of goods sold is $1.36 million

ALBO Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+63.9%+16.8%-2363.7%
3 y3 years+285.2%+242.2%-6407.5%
5 y5 years+356.3%+454.4%-6407.5%

ALBO Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-4.8%-18.0%+16.0%at low
5 y5-yearat high-67.0%-4.8%-70.0%+161.6%at low
alltimeall timeat high-99.0%-4.8%-94.5%>+9999.0%at low

Albireo Pharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2022
-
$20.56 M(-4.8%)
$78.76 M(+3.9%)
Jun 2022
-
$21.60 M(+28.2%)
$75.81 M(+6.5%)
Mar 2022
-
$16.86 M(-14.6%)
$71.15 M(+2.3%)
Dec 2021
$69.57 M(+63.9%)
$19.74 M(+12.1%)
$69.57 M(+8.7%)
Sep 2021
-
$17.61 M(+4.0%)
$63.98 M(+10.3%)
Jun 2021
-
$16.94 M(+10.9%)
$58.03 M(+17.1%)
Mar 2021
-
$15.27 M(+7.9%)
$49.57 M(+16.8%)
Dec 2020
$42.45 M(+84.9%)
$14.16 M(+21.4%)
$42.45 M(+23.2%)
Sep 2020
-
$11.66 M(+37.6%)
$34.47 M(+19.6%)
Jun 2020
-
$8.47 M(+3.9%)
$28.81 M(+11.6%)
Mar 2020
-
$8.15 M(+32.0%)
$25.82 M(+12.5%)
Dec 2019
$22.96 M(+27.1%)
$6.17 M(+2.7%)
$22.96 M(+1.5%)
Sep 2019
-
$6.01 M(+9.6%)
$22.63 M(+10.6%)
Jun 2019
-
$5.49 M(+3.6%)
$20.47 M(+6.5%)
Mar 2019
-
$5.29 M(-9.4%)
$19.23 M(+6.5%)
Dec 2018
$18.06 M(+18.5%)
$5.84 M(+51.8%)
$18.06 M(+7.3%)
Sep 2018
-
$3.85 M(-9.2%)
$16.83 M(+0.8%)
Jun 2018
-
$4.24 M(+2.7%)
$16.69 M(+3.2%)
Mar 2018
-
$4.13 M(-10.5%)
$16.16 M(+6.0%)
Dec 2017
$15.25 M(-3.4%)
$4.61 M(+24.3%)
$15.25 M(+43.4%)
Sep 2017
-
$3.71 M(-0.1%)
$10.63 M(+24.3%)
Jun 2017
-
$3.71 M(+15.6%)
$8.56 M(+8.6%)
Mar 2017
-
$3.21 M(+96.8%)
$7.88 M(-23.4%)
Dec 2016
$15.79 M(+53.4%)
-
-
Sep 2016
-
$1.63 M(-46.2%)
$10.29 M(+2.0%)
Sep 2016
$10.29 M(+60.7%)
-
-
Jun 2016
-
$3.04 M(-23.9%)
$10.09 M(+17.6%)
Mar 2016
-
$3.99 M(+144.4%)
$8.58 M(+38.3%)
Dec 2015
-
$1.63 M(+13.9%)
$6.20 M(-3.1%)
Sep 2015
$6.40 M(+14.4%)
$1.43 M(-6.0%)
$6.40 M(+5.1%)
Jun 2015
-
$1.52 M(-5.3%)
$6.09 M(+3.0%)
Mar 2015
-
$1.61 M(-12.1%)
$5.92 M(-2.0%)
Dec 2014
-
$1.83 M(+63.2%)
$6.04 M(+7.8%)
DateAnnualQuarterlyTTM
Sep 2014
$5.60 M(-18.2%)
$1.12 M(-16.7%)
$5.60 M(-5.9%)
Jun 2014
-
$1.35 M(-22.1%)
$5.95 M(-6.6%)
Mar 2014
-
$1.73 M(+24.0%)
$6.37 M(-6.5%)
Dec 2013
-
$1.40 M(-5.2%)
$6.81 M(-0.5%)
Sep 2013
$6.84 M(-3.2%)
$1.47 M(-16.7%)
$6.84 M(+0.4%)
Jun 2013
-
$1.77 M(-18.7%)
$6.82 M(-0.1%)
Mar 2013
-
$2.17 M(+52.1%)
$6.83 M(+5.3%)
Dec 2012
-
$1.43 M(-1.2%)
$6.48 M(-8.4%)
Sep 2012
$7.07 M(-26.5%)
$1.45 M(-18.6%)
$7.07 M(-11.5%)
Jun 2012
-
$1.78 M(-3.0%)
$7.99 M(-7.1%)
Mar 2012
-
$1.83 M(-9.4%)
$8.59 M(-5.2%)
Dec 2011
-
$2.02 M(-14.4%)
$9.07 M(-5.8%)
Sep 2011
$9.63 M(-12.3%)
$2.36 M(-0.9%)
$9.63 M(-0.5%)
Jun 2011
-
$2.38 M(+3.3%)
$9.67 M(-4.0%)
Mar 2011
-
$2.31 M(-10.6%)
$10.07 M(-9.6%)
Dec 2010
-
$2.58 M(+7.1%)
$11.14 M(+1.5%)
Sep 2010
$10.98 M(-0.1%)
$2.41 M(-13.4%)
$10.98 M(-1.6%)
Jun 2010
-
$2.78 M(-17.7%)
$11.16 M(+0.8%)
Mar 2010
-
$3.38 M(+39.7%)
$11.07 M(-0.5%)
Dec 2009
-
$2.42 M(-6.5%)
$11.13 M(+1.2%)
Sep 2009
$10.99 M(-25.7%)
$2.59 M(-3.9%)
$10.99 M(-3.3%)
Jun 2009
-
$2.69 M(-21.6%)
$11.37 M(-11.4%)
Mar 2009
-
$3.44 M(+50.6%)
$12.84 M(-0.7%)
Dec 2008
-
$2.28 M(-23.0%)
$12.94 M(-12.5%)
Sep 2008
$14.80 M(+76.5%)
$2.96 M(-28.8%)
$14.79 M(-6.0%)
Jun 2008
-
$4.16 M(+17.8%)
$15.74 M(+19.0%)
Mar 2008
-
$3.53 M(-14.5%)
$13.22 M(+18.1%)
Dec 2007
-
$4.13 M(+5.7%)
$11.20 M(+33.2%)
Sep 2007
$8.39 M(+441.7%)
$3.91 M(+137.2%)
$8.41 M(+87.0%)
Jun 2007
-
$1.65 M(+9.6%)
$4.50 M(+57.9%)
Mar 2007
-
$1.50 M(+12.0%)
$2.85 M(+112.0%)
Dec 2006
-
$1.34 M
$1.34 M
Sep 2006
$1.55 M(+113.8%)
-
-
Sep 2005
$724.00 K
-
-

FAQ

  • What is Albireo Pharma annual SGA?
  • What is the all time high annual SGA for Albireo Pharma?
  • What is Albireo Pharma annual SGA year-on-year change?
  • What is Albireo Pharma quarterly SGA?
  • What is the all time high quarterly SGA for Albireo Pharma?
  • What is Albireo Pharma quarterly SGA year-on-year change?
  • What is Albireo Pharma TTM SGA?
  • What is the all time high TTM SGA for Albireo Pharma?
  • What is Albireo Pharma TTM SGA year-on-year change?

What is Albireo Pharma annual SGA?

The current annual SGA of ALBO is $69.57 M

What is the all time high annual SGA for Albireo Pharma?

Albireo Pharma all-time high annual SGA is $69.57 M

What is Albireo Pharma annual SGA year-on-year change?

Over the past year, ALBO annual SGA has changed by +$27.12 M (+63.89%)

What is Albireo Pharma quarterly SGA?

The current quarterly SGA of ALBO is $20.56 M

What is the all time high quarterly SGA for Albireo Pharma?

Albireo Pharma all-time high quarterly SGA is $21.60 M

What is Albireo Pharma quarterly SGA year-on-year change?

Over the past year, ALBO quarterly SGA has changed by +$2.95 M (+16.76%)

What is Albireo Pharma TTM SGA?

The current TTM SGA of ALBO is -$1.45 B

What is the all time high TTM SGA for Albireo Pharma?

Albireo Pharma all-time high TTM SGA is -$4.16 M

What is Albireo Pharma TTM SGA year-on-year change?

Over the past year, ALBO TTM SGA has changed by -$1.51 B (-2363.73%)